HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ken Ikeda Selected Research

Cyclosporine (Ciclosporin)

3/2007Amelioration of collagen-induced arthritis in mice by a novel phosphodiesterase 7 and 4 dual inhibitor, YM-393059.
11/2006Pharmacological profile of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on acute and chronic inflammation models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ken Ikeda Research Topics

Disease

12Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2022 - 07/2002
10Parkinson Disease (Parkinson's Disease)
06/2019 - 01/2002
6Motor Neuron Disease (Primary Lateral Sclerosis)
07/2015 - 03/2002
5Migraine Disorders (Migraine)
04/2018 - 09/2006
5Overactive Urinary Bladder (Overactive Bladder)
12/2006 - 08/2002
4Dyskinesias (Dyskinesia)
01/2018 - 01/2002
4Muscle Weakness
07/2015 - 09/2002
3Parkinsonian Disorders (Parkinsonism)
06/2019 - 12/2004
3Atrophy
01/2015 - 10/2009
3Alzheimer Disease (Alzheimer's Disease)
01/2014 - 01/2013
3Disease Progression
01/2013 - 01/2011
3Facial Nerve Injuries
02/2011 - 06/2003
2Neoplasms (Cancer)
07/2020 - 11/2009
2Headache (Headaches)
05/2017 - 01/2009
2Dyslipidemias (Dyslipidemia)
03/2017 - 01/2011
2Epilepsy (Aura)
03/2017 - 01/2011
2Cerebral Infarction
03/2017 - 01/2015
2Contracture
07/2015 - 01/2015
2Ischemic Stroke
12/2012 - 01/2008
2Diabetes Mellitus
01/2011 - 09/2002
2Stroke (Strokes)
01/2011 - 01/2008
2Pruritus (Itching)
11/2010 - 04/2008
2Schizophrenia (Dementia Praecox)
11/2010 - 03/2009
2Hypertension (High Blood Pressure)
07/2010 - 05/2010
1Severe Acute Respiratory Syndrome
01/2022
1Communicable Diseases (Infectious Diseases)
01/2022
1Biliary Tract Neoplasms (Biliary Tract Cancer)
07/2020
1Essential Tremor (Essential Tremors)
06/2019
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
03/2017
1Abdominal Pain (Pain, Abdominal)
01/2017
1Pathologic Constriction (Stenosis)
01/2017
1Colonic Neoplasms (Colon Cancer)
01/2017
1Cerebrotendinous Xanthomatosis
02/2016
1Dementia (Dementias)
10/2014
1Carbon Monoxide Poisoning (Poisoning, Carbon Monoxide)
03/2014
1Poisoning
03/2014
1Dystonia (Limb Dystonia)
01/2014

Drug/Important Bio-Agent (IBA)

4Pharmaceutical PreparationsIBA
06/2019 - 08/2002
4LipidsIBA
03/2017 - 01/2011
4TRK 820IBA
11/2010 - 04/2008
4kappa Opioid Receptors (kappa Opioid Receptor)IBA
11/2010 - 04/2008
4T 588IBA
07/2007 - 03/2002
4Solifenacin SuccinateFDA Link
12/2006 - 08/2002
4oxybutynin (Tavor)FDA LinkGeneric
10/2005 - 08/2002
3mecobalamin (methylcobalamin)IBA
01/2022 - 07/2015
3lomerizineIBA
04/2018 - 01/2011
3Calcium Channel Blockers (Blockers, Calcium Channel)IBA
04/2018 - 01/2011
3MethylprednisoloneFDA LinkGeneric
03/2014 - 01/2011
3Levodopa (L Dopa)FDA LinkGeneric
01/2013 - 08/2008
3AntibodiesIBA
01/2013 - 11/2010
3olmesartanIBA
05/2010 - 07/2002
3N- (4,6- dimethylpyrimidin- 2- yl)- 4- (2- (4- methoxy- 3- methylphenyl)- 5- (4- methylpiperazin- 1- yl)- 4,5,6,7- tetrahydro- 1H- indol- 1- yl)benzenesulfonamide difumarateIBA
03/2007 - 07/2006
3Muscarinic AntagonistsIBA
05/2004 - 08/2002
2Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
06/2019 - 01/2018
2Selegiline (E250)FDA LinkGeneric
01/2018 - 01/2013
2Dopamine Agonists (Dopamine Agonist)IBA
01/2018 - 01/2016
2Angiotensin Receptor AntagonistsIBA
05/2017 - 05/2010
2SteroidsIBA
01/2017 - 01/2011
2Neuroprotective AgentsIBA
07/2015 - 01/2002
2Memantine (Namenda)FDA Link
03/2014 - 01/2013
2Donepezil (Aricept)FDA LinkGeneric
01/2014 - 01/2013
2Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2014 - 01/2013
2IronIBA
09/2013 - 01/2012
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2013 - 01/2013
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2012 - 01/2011
2Uric Acid (Urate)IBA
01/2012 - 01/2011
2Ferritins (Ferritin)IBA
01/2012 - 01/2011
2Prednisolone (Predate)FDA LinkGeneric
01/2011 - 01/2011
2Immunoglobulin G (IgG)IBA
01/2011 - 11/2010
2AntipruriticsIBA
11/2010 - 04/2008
2Superoxide Dismutase-1IBA
01/2010 - 10/2005
2Cyclosporine (Ciclosporin)FDA LinkGeneric
03/2007 - 11/2006
2darifenacinFDA Link
05/2004 - 01/2004
2Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
05/2004 - 01/2004
2Tolterodine Tartrate (Detrol)FDA Link
05/2004 - 01/2004
1VaccinesIBA
01/2022
1Monoclonal AntibodiesIBA
01/2022
1Zonisamide (Zonegran)FDA LinkGeneric
01/2018
1entacapone (Comtan)FDA Link
01/2018
1Telmisartan (Micardis)FDA Link
05/2017
1Tryptamines (Triptans)IBA
05/2017
1Analgesics (Analgesic Drugs)IBA
05/2017
1Anticonvulsants (Antiepileptic Drugs)IBA
03/2017
1SterolsIBA
02/2016
1Cholestanetriol 26-Monooxygenase (Cholestanetriol 26 Monooxygenase)IBA
02/2016
1rotigotineFDA Link
01/2016
1EdaravoneIBA
01/2015
1Free Radical ScavengersIBA
01/2015
1Amyloid (Amyloid Fibrils)IBA
10/2014
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2014

Therapy/Procedure

12Therapeutics
07/2020 - 01/2002
3Denervation
01/2015 - 10/2009
3Oral Administration
01/2011 - 06/2003
3Drug Therapy (Chemotherapy)
11/2009 - 08/2002
2Renal Dialysis (Hemodialysis)
11/2010 - 04/2008
1Tracheostomy
01/2022
1Decompression
01/2017
1Colectomy
01/2017
1Transdermal Patch
01/2016
1Hyperbaric Oxygenation
03/2014